Read + Share
Amedeo Smart
Independent Medical Education
Ratziu V, Harrison SA, Loustaud-Ratti V, Bureau C, et al. Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH. J Hepatol 2022 Nov 2. pii: S0168-8278(22)03160.PMID: 36334688
Email
LinkedIn
Facebook
Twitter
Privacy Policy